Login / Signup

The potential impact of COVID-19-related disruption on tuberculosis burden.

C Finn McQuaidNicky McCreeshJonathan M ReadTom Sumnernull nullRein M G J HoubenRichard G WhiteRebecca C Harris
Published in: The European respiratory journal (2020)
Keyphrases
  • coronavirus disease
  • sars cov
  • mycobacterium tuberculosis
  • pulmonary tuberculosis
  • hiv aids
  • human health
  • emergency department
  • adverse drug
  • respiratory syndrome coronavirus
  • hepatitis c virus
  • antiretroviral therapy